Markets

The regenerative medicine market is projected to reach $40.6 billion by 2027 from $12.2 billion in 2022, at a CAGR of 27.2%

ReportLinker

ReportLinker

during the forecast period. Market growth is driven by the availability of funding and growing investment in research and development, increasing clinical trials for stem cell and CAR-T cell therapies, and growing advances in tissue-engineered products.

New York, Dec. 26, 2022 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Regenerative Medicine Market by Product, Gene Therapy, Tissue Engineering, Application, Region – Global Forecast to 2027” – https:// vvv.reportlinker. com/p04700208/?utm_source=GNV
However, high treatment costs of RM therapy and commercialization and regulation are expected to restrain market growth during the forecast period.

By application, the musculoskeletal disorders segment held the largest share of the regenerative medicine market
On the basis of applications, the regenerative medicine market is segmented into musculoskeletal disorders, wound care, oncology, eye disorders, dentistry, and other applications. In 2021, the musculoskeletal disorders segment held the largest market share.

This can be attributed to the increasing prevalence of orthopedic diseases, the growing geriatric population, the increasing number of stem cell research projects, the growing number of clinical research/trials and the rich array of stem cell products for the treatment of musculoskeletal disorders.

Asia Pacific: The fastest growing region in the regenerative medicine market.

The Asia Pacific market is projected to grow at the highest CAGR during the forecast period, mainly due to increasing research activities in Asian countries, availability of research funding, and increasing number of biobanks and research centers driving the growth of the Asia Pacific regenerative medicine market.

North America: largest share of the regenerative medicine market
North America accounted for the largest share of the regenerative medicine market. Factors such as establishment of stem cell banking, tissue engineering, rise in demand for treatments based on advanced technology such as stem cell technology, biologics, tissue engineering and biomaterials.

The primary interviews conducted for this report can be categorized as follows:
• From the respondents: supply side – 80% and demand side 20%
• By grade: C-level – 25%, D-level – 20%, and others – 55%
• By region: North America -50%, Europe -20%, Asia-Pacific -20%, Latin America -5%, Middle East and Africa – 5%

The main players
• Novartis AG (Switzerland)
• Biogen (USA)
• Sarepta Therapeutics, Inc. (USA)
• Gilead Sciences, Inc. (USA)
• Amgen, Inc. (USA)
• Smith & Nephew plc (UK)
• MEDIPOST Co., Ltd. (South Korea)
• JCR Pharmaceuticals Co., Ltd (Japan)
• Pharmaceutical company Takeda (Japan)
• CORESTEM Inc (South Korea)
• Vericel Corporation (USA)
• MIMEDX (USA)
• Organogenesis Inc. (USA)
• Medtronic plc (USA)
• Orthocell Ltd. (Australia)
• Mesoblast Ltd (Australia)
• Biorestorative therapies (USA)
• Pluri Inc, (Israel)
• Tegoscience (South Korea)
• Anterogen Co., Ltd. (South Korea)
• Bluebird Bio (USA)
• APAC Biotech (India)
• Shenzhen Sibiono Genetech Co., Ltd. (China)
• Aspect Biosystems (Canada)
• Athersis, Inc. (USA)

Research coverage:
This report provides a detailed picture of the regenerative medicine market. It aims to estimate the size and future growth potential of the market in various segments such as product, application, and region.

The report also includes a detailed competitive analysis of key market players along with their company profiles, recent developments and key market strategies.

Key benefits of purchasing a report:
The report will help the market leaders/new entrants by providing them with the closest approximate revenue numbers for the overall Regenerative Medicine market and its segments. It will also help stakeholders better understand the competitive environment and gain more insights to better position their business and make appropriate go-to-market strategies.

This report will enable stakeholders to understand the pulse of the market and provide them with information on key market drivers, restraints, trends, opportunities and challenges.
Read the full report: https://www.reportlinker.com/p04700208/?utm_source=GNV

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001

Source link

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button